Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Ther Drug Monit. 2023 Jan 13;45(4):539–545. doi: 10.1097/FTD.0000000000001052

Figure 1.

Figure 1.

Diagnostic plots for the fexofenadine population pharmacokinetic model. Conditional weighted residuals versus time after dosing (A) and individual predicted concentrations (B). Fexofenadine concentrations versus individually predicted concentrations (C) and population-predicted concentrations (D).